4.8 Review

Akkermansia muciniphila and Gut Immune System: A Good Friendship That Attenuates Inflammatory Bowel Disease, Obesity, and Diabetes

Related references

Note: Only part of the references are listed.
Article Microbiology

Increased circulating butyrate and ursodeoxycholate during probiotic intervention in humans with type 2 diabetes

Paul J. McMurdie et al.

Summary: This study demonstrates an increase in circulating butyrate and ursodeoxycholate following probiotic intervention in humans with T2D, suggesting a potential targeted microbiome-based approach for managing T2D. The efficient synthesis of UDCA by C. butyricum may also be of interest for probiotic use in other disease settings. Additionally, the inhibitory interaction between sulfonylurea drugs and gut microbiota should be carefully considered in future study designs.

BMC MICROBIOLOGY (2022)

Article Cell Biology

Beneficial Effects of Akkermansia muciniphila Are Not Associated with Major Changes in the Circulating Endocannabinoidome but Linked to Higher Mono-Palmitoyl-Glycerol Levels as New PPARα Agonists

Clara Depommier et al.

Summary: A. muciniphila is considered as a beneficial bacterium for obesity and metabolic disorders, and this study suggests that its effects may be mediated through modulation of certain endocannabinoid-related lipids. Specifically, the bacterium counteracted the decrease in 1-PG and 2-PG observed in overweight or obese individuals, which are endogenous activators of PPAR alpha, potentially explaining some of the beneficial metabolic effects induced by A. muciniphila in human metabolic syndrome.

CELLS (2021)

Article Biotechnology & Applied Microbiology

Extracellular vesicles and pasteurized cells derived from Akkermansia muciniphila protect against high-fat induced obesity in mice

Fatemeh Ashrafian et al.

Summary: The study showed that pasteurized A. muciniphila and its EVs have preventive effects on HFD-induced obesity, with more noticeable effects than its active form. These treatments also inhibited inflammation and gene expression changes related to lipid metabolism caused by HFD, indicating a potential role in regulating metabolic functions to prevent obesity.

MICROBIAL CELL FACTORIES (2021)

Article Microbiology

Akkermansia muciniphila Alleviates Dextran Sulfate Sodium (DSS)-Induced Acute Colitis by NLRP3 Activation

Siwen Qu et al.

Summary: Akkermansia muciniphila has been shown to play a crucial role in the progression of colitis, with its protective effects in acute colitis depending on NLRP3 activation. This study enriches the understanding of the mechanisms underlying A. muciniphila's effects and offers a new prospect for probiotic-based treatments of colitis. The interaction between gut microbiota and host immune response plays a significant role in intestinal inflammatory diseases.

MICROBIOLOGY SPECTRUM (2021)

Article Microbiology

Effects of Live and Pasteurized Forms of Akkermansia from the Human Gut on Obesity and Metabolic Dysregulation

Yura Choi et al.

Summary: This study compared the effects of two forms of A. muciniphila on metabolism and immunity, showing that both forms improved obesity and metabolic dysregulation caused by a high-fat diet, while also exhibiting anti-inflammatory properties.

MICROORGANISMS (2021)

Article Microbiology

Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice

Hyo Shin Yoon et al.

Summary: The study demonstrates that Akkermansia muciniphila increases thermogenesis and GLP-1 secretion in mice by inducing uncoupling protein 1. A protein secreted by A. muciniphila, P9, interacts with ICAM-2 and can target metabolic diseases. This interaction could be a potential therapeutic target for such diseases.

NATURE MICROBIOLOGY (2021)

Article Multidisciplinary Sciences

Comparative effects of alive and pasteurized Akkermansia muciniphila on normal diet-fed mice

Fatemeh Ashrafian et al.

Summary: The study found that Akkermansia muciniphila can improve gut health by enhancing intestinal integrity and maintaining immune homeostasis, with the pasteurized form showing more pronounced effects.

SCIENTIFIC REPORTS (2021)

Article Chemistry, Multidisciplinary

Decreased Abundance of Akkermansia muciniphila Leads to the Impairment of Insulin Secretion and Glucose Homeostasis in Lean Type 2 Diabetes

Jing Zhang et al.

Summary: The study found that the decreased abundance of A. muciniphila in lean individuals with T2D is associated with impaired insulin secretion and glucose homeostasis, and supplementation of A. muciniphila can protect mice from sucrose-induced damage.

ADVANCED SCIENCE (2021)

Article Microbiology

Novel insights into the genetically obese (ob/ob) and diabetic (db/db) mice: two sides of the same coin

Franc Suriano et al.

Summary: Results from studying ob/ob and db/db mice show significant differences in glucose metabolism, fat distribution, liver steatosis, and inflammatory profiles, despite both being severely obese. These differences may be attributed to variations in gut microbiota composition, short-chain fatty acids, bile acid metabolism, inflammatory tones, serum LPS concentration, and leptin signaling alterations.

MICROBIOME (2021)

Article Gastroenterology & Hepatology

Mucin degrader Akkermansia muciniphila accelerates intestinal stem cell-mediated epithelial development

Seungil Kim et al.

Summary: Mucin-degrading bacteria, such as A. muciniphila, can promote the proliferation of intestinal stem cells and differentiation of specific cell types in the small intestine and colon. Additionally, treatment with A. muciniphila leads to higher levels of acetic and propionic acids in the cecal contents of mice. Furthermore, pre-treatment with A. muciniphila can reduce gut damage caused by radiation and methotrexate, suggesting a potential role in intestinal homeostasis maintenance.

GUT MICROBES (2021)

Article Biotechnology & Applied Microbiology

Akkermansia muciniphila Prevents Fatty Liver Disease, Decreases Serum Triglycerides, and Maintains Gut Homeostasis

Sejeong Kim et al.

APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2020)

Review Gastroenterology & Hepatology

Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review

Rapat Pittayanon et al.

GASTROENTEROLOGY (2020)

Review Gastroenterology & Hepatology

Is there any association between gut microbiota and type 1 diabetes? A systematic review

Parnian Jamshidi et al.

GUT PATHOGENS (2019)

Review Food Science & Technology

A next generation probiotic, Akkermansia muciniphila

Qixiao Zhai et al.

CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2019)

Review Endocrinology & Metabolism

Gut microbiome in type 1 diabetes: A comprehensive review

Peilin Zheng et al.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2018)

Review Genetics & Heredity

Epigenetic regulation of Toll-like receptors and its roles in type 1 diabetes

Zhiguo Xie et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2018)

Article Biochemistry & Molecular Biology

Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions

Chaithanya Chelakkot et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2018)

Review Medicine, General & Internal

Is there a role for gut microbiota in type 1 diabetes pathogenesis?

Stefano Bibbo et al.

ANNALS OF MEDICINE (2017)

Review Primary Health Care

An Update on Inflammatory Bowel Disease

Tomoko Sairenji et al.

PRIMARY CARE (2017)

Review Biochemistry & Molecular Biology

Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics

Mingqian He et al.

CELL AND BIOSCIENCE (2017)

Article Multidisciplinary Sciences

Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study

Pieter F. de Groot et al.

PLOS ONE (2017)

Article Gastroenterology & Hepatology

Changes in intestinal microbiota composition and metabolism coincide with increased intestinal permeability in young adults under prolonged physiological stress

J. Philip Karl et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2017)

Article Immunology

Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to T1D onset

Frederico R. C. Costa et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2016)

Article Multidisciplinary Sciences

Akkermansia muciniphila mediates negative effects of IFNγ on glucose metabolism

Renee L. Greer et al.

NATURE COMMUNICATIONS (2016)

Article Genetics & Heredity

Sub-clinical detection of gut microbial biomarkers of obesity and type 2 diabetes

Moran Yassour et al.

GENOME MEDICINE (2016)

Review Gastroenterology & Hepatology

Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism

Douglas J. Morrison et al.

GUT MICROBES (2016)

Article Gastroenterology & Hepatology

Microbiota and diabetes: an evolving relationship

Herbert Tilg et al.

Article Gastroenterology & Hepatology

Inflammatory bowel disease: Pathogenesis

Yi-Zhen Zhang et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Multidisciplinary Sciences

The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism

Gary Frost et al.

NATURE COMMUNICATIONS (2014)

Review Microbiology

Colonic bacterial metabolites and human health

Wendy R. Russell et al.

CURRENT OPINION IN MICROBIOLOGY (2013)

Article Multidisciplinary Sciences

Human Gut Microbiota Changes Reveal the Progression of Glucose Intolerance

Xiuying Zhang et al.

PLOS ONE (2013)

Article Multidisciplinary Sciences

Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity

Amandine Everard et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Review Immunology

Oral tolerance to food protein

O. Pabst et al.

MUCOSAL IMMUNOLOGY (2012)

Article Multidisciplinary Sciences

A metagenome-wide association study of gut microbiota in type 2 diabetes

Junjie Qin et al.

NATURE (2012)

Article Endocrinology & Metabolism

The Microbiota of the Gut in Preschool Children With Normal and Excessive Body Weight

Caroline L. J. Karlsson et al.

OBESITY (2012)

Article Gastroenterology & Hepatology

NLRP3 Inflammasome Plays a Key Role in the Regulation of Intestinal Homeostasis

Simon A. Hirota et al.

INFLAMMATORY BOWEL DISEASES (2011)

Review Gastroenterology & Hepatology

Importance of Disrupted Intestinal Barrier in Inflammatory Bowel Diseases

Sa'ad Y. Salim et al.

INFLAMMATORY BOWEL DISEASES (2011)

Article Gastroenterology & Hepatology

Intestinal microbiota in inflammatory bowel disease: Friend of foe?

Francesca Fava et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2011)

Article Gastroenterology & Hepatology

Association Between the Use of Antibiotics in the First Year of Life and Pediatric Inflammatory Bowel Disease

Souradet Y. Shaw et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)

Review Gastroenterology & Hepatology

Probiotic bacteria and intestinal epithelial barrier function

Christina L. Ohland et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)

Article Medicine, Research & Experimental

Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue

Aliki Kosteli et al.

JOURNAL OF CLINICAL INVESTIGATION (2010)

Article Biotechnology & Applied Microbiology

The mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract

Muriel Derrien et al.

APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2008)

Review Gastroenterology & Hepatology

Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases

A Fasano et al.

NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2005)

Article Microbiology

Akkermansia muciniphila gen. nov., sp nov., a human intestinal mucin-degrading bacterium

M Derrien et al.

INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2004)

Article Multidisciplinary Sciences

A central role for JNK in obesity and insulin resistance

J Hirosumi et al.

NATURE (2002)